CG
TCON

Cutler Group’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

Cutler Group’s Portfolio TCON Stock Details TCON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-60
Closed – – 3914
2023
Q4 		$0 Hold
60
– – ﹤0.01% 4534
2023
Q3 		$0 Hold
60
– – ﹤0.01% 4464
2023
Q2 		$0 Hold
60
– – ﹤0.01% 4340
2023
Q1 		$2K Hold
60
– – ﹤0.01% 3292
2022
Q4 		$1K Hold
60
– – ﹤0.01% 4228
2022
Q3 		$2K Hold
60
– – ﹤0.01% 4359
2022
Q2 		$2K Sell
60
-750
-93% -$29K ﹤0.01% 4421
2022
Q1 		$42K Hold
810
– – ﹤0.01% 2409
2021
Q4 		$44K Buy
810
+750
+1,250% +$47.9K ﹤0.01% 2507
2021
Q3 		$4K Hold
60
– – ﹤0.01% 4711
2021
Q2 		$7K Hold
60
– – ﹤0.01% 4247
2021
Q1 		$9K Buy
+60
New +$11.6K ﹤0.01% 3934

Other funds holding TCON

LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return

Cutler Group's TCON Position: Q1 2024 in Review

Cutler Group sold out of TRACON Pharmaceuticals, Inc. Common Stock (TCON) in Q1 2024, closing a stake of 60 shares.

Cutler Group first reported a position in TCON in Q1 2021 and held it in 12 quarters. The position peaked at $44K in Q4 2021. 29 funds tracked by Wall St. Rank hold TCON as of Q1 2024.

  • Cutler Group reported no remaining TRACON Pharmaceuticals, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Cutler Group sold 60 TRACON Pharmaceuticals, Inc. Common Stock shares in Q1 2024.
  • Cutler Group first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q1 2021 and held it in 12 quarters.
  • Cutler Group's TRACON Pharmaceuticals, Inc. Common Stock position peaked at $44K in Q4 2021.
  • 29 funds tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.